NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Lupin Limited (NSE: LUPIN)
LUPIN Technical Analysis
4
As on 28th Mar 2024 LUPIN SHARE Price closed @ 1616.80 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1155.07 & Buy for SHORT-TERM with Stoploss of 1557.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LUPINSHARE Price
Open | 1611.00 | Change | Price | % |
High | 1625.00 | 1 Day | 16.85 | 1.05 |
Low | 1593.10 | 1 Week | 5.15 | 0.32 |
Close | 1616.80 | 1 Month | 0.45 | 0.03 |
Volume | 865183 | 1 Year | 972.40 | 150.90 |
52 Week High 1081.15 | 52 Week Low 590.25 |
LUPIN CURRENT MONTH FUTURE | |||
Close | 1614.20 | ||
Contracts Traded | 3372800 | ||
Open Intrest | 213350 | ||
Change In O.I | -91.44 % | ||
Lot Size | 850 |
LUPIN CURRENT MONTH OPTION | |
Most Active Call | 1640.00 |
Most Active put | 1600.00 |
Highest O.I Buildup Call | 1700.00 |
Highest O.I Buildup Put | 1500.00 |
Expiry Date | 2024-03-28 |
LUPIN ALL MONTHS OPTIONS | |||
For All LUPIN Options Click Here |
NSE INDIA Most Active Stocks
IDEA | 13.25 | -0.38% |
IDFCFIRSTB | 75.40 | -3.08% |
YESBANK | 23.20 | 0.22% |
GTLINFRA | 1.60 | 0.00% |
NHPC | 89.70 | 0.96% |
TATASTEEL | 155.85 | 2.06% |
BCG | 13.80 | -1.08% |
MAHABANK | 62.35 | 5.41% |
IRFC | 142.35 | -0.35% |
SOUTHBANK | 27.25 | -1.80% |
NSE INDIA Top Gainers Stocks
GOCLCORP | 454.60 | 19.99% |
NRL | 90.70 | 15.32% |
AEGISCHEM | 446.65 | 13.18% |
VIPIND | 525.50 | 12.89% |
REPRO | 834.35 | 12.02% |
GENESYS | 591.45 | 10.91% |
ONELIFECAP | 30.25 | 10.00% |
IFBIND | 1505.95 | 9.98% |
WEIZMANIND | 110.85 | 9.97% |
OMAXE | 90.55 | 9.96% |
NSE INDIA Top Losers Stocks
PERSISTENT | 3984.55 | -50.81% |
SITINET | 0.55 | -8.33% |
RACE | 325.10 | -6.35% |
RACE | 325.10 | -6.35% |
FCONSUMER | 0.75 | -6.25% |
KHANDSE | 29.35 | -6.23% |
CAMLINFINE | 89.25 | -6.10% |
ORIENTBELL | 347.15 | -6.06% |
KOHINOOR | 38.75 | -5.95% |
DWARKESH | 69.50 | -5.89% |
LUPIN Daily Charts |
LUPIN Intraday Charts |
Whats New @ Bazaartrend |
LUPIN Free Analysis |
|
LUPIN Important Levels Intraday
RESISTANCE | 1678.27 |
RESISTANCE | 1658.56 |
RESISTANCE | 1646.37 |
RESISTANCE | 1634.19 |
SUPPORT | 1599.41 |
SUPPORT | 1587.23 |
SUPPORT | 1575.04 |
SUPPORT | 1555.33 |
LUPIN Target March 2024
4th UP Target | 2132.65 |
3rd UP Target | 1934.15 |
2nd UP Target | 1811.45 |
1st UP Target | 1688.75 |
1st DOWN Target | 1338.65 |
2nd DOWN Target | 1215.95 |
3rd DOWN Target | 1093.25 |
4th DOWN Target | 894.75 |
LUPIN Weekly Target
4th UP Target | 1844.11 |
3rd UP Target | 1768.47 |
2nd UP Target | 1721.71 |
1st UP Target | 1674.96 |
1st DOWN Target | 1541.54 |
2nd DOWN Target | 1494.79 |
3rd DOWN Target | 1448.03 |
4th DOWN Target | 1372.39 |
LUPIN Target2024
4th UP Target | 2708.17 |
3rd UP Target | 2263.92 |
2nd UP Target | 1989.32 |
1st UP Target | 1714.72 |
1st DOWN Target | 931.18 |
2nd DOWN Target | 656.58 |
3rd DOWN Target | 381.98 |
4th DOWN Target | -62.27 |
Lupin Limited ( NSE INDIA Symbol : LUPIN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LUPIN Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is 35.09 | Sideways | |
MFI (14) | MFI is 34.49 | Sideways | |
CCI (20) | CCI is -80.13 | Sideways | |
WILLIAM %R (14) | William %R is -40.54 | Sideways | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 663.86 | |
10 Day Avg Volume | Traded -7.53 % Less then 10 Day Average Volume |
LUPIN Other Details
Segment | EQ | |
Market Capital | 426989584384.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
LUPIN Address
LUPIN Latest News
LUPIN Business Profile
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, active pharmaceutical ingredients (APIs), and specialty products in India, the United States, Japan, and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, anti-tuberculosis, and cephalosporin, as well as digital therapeutics platform for doctors and patients. The company is also involved in the provision of biosimilar and over-the-counter products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It has a licensing, development, and commercialization agreement with Boehringer Ingelheim for Lupin's MEK inhibitor compound (LNP3794) as a potential targeted therapy for patients with cancers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. Address: Kalpataru Inspire, Mumbai, India, 400055
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service